On May 28, 2020, Bayer China, a leading company in the Chinese pharmaceutical scene,  revealed plans of co-developing a Clinical Trial Traceability Platform based on the VeChain blockchain called cSecure. This solution monitors user and product data ensuring consistency throughout the trial of clinical drugs thereby improving precision and safety.  VeChain and Bayer China Deal

Read MoreRead More. The post by Dalmas Ngetich appeared first on BTCManager, Bitcoin, Blockchain & Cryptocurrency News\

Source and More information: VeChain (VET) Partners Bayer China to Improve Management of Clinical Trial Drugs

Author: BTCManager.com